Royalty Pharma Plc (RPRX)
61.33
+0.02
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
61.32
-0.01
(-0.02%)
After-Hours: 20:00
Royalty Pharma Max Drawdown (5Y) : 49.68% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 49.68% |
| June 30, 2026 | 49.68% |
| May 31, 2026 | 49.68% |
| April 30, 2026 | 49.68% |
| March 31, 2026 | 49.68% |
| February 28, 2026 | 49.68% |
| January 31, 2026 | 49.68% |
| December 31, 2025 | 49.68% |
| November 30, 2025 | 49.68% |
| October 31, 2025 | 49.68% |
| September 30, 2025 | 49.68% |
| August 31, 2025 | 49.68% |
| July 31, 2025 | 49.68% |
| June 30, 2025 | 49.68% |
| May 31, 2025 | 49.68% |
| April 30, 2025 | 49.68% |
| March 31, 2025 | 49.68% |
| February 28, 2025 | 49.68% |
| January 31, 2025 | 49.68% |
| December 31, 2024 | 49.68% |
| November 30, 2024 | 47.72% |
| October 31, 2024 | 47.72% |
| September 30, 2024 | 47.72% |
| August 31, 2024 | 47.72% |
| July 31, 2024 | 47.72% |
| Date | Value |
|---|---|
| June 30, 2024 | 47.70% |
| May 31, 2024 | 47.70% |
| April 30, 2024 | 47.70% |
| March 31, 2024 | 47.70% |
| February 29, 2024 | 47.70% |
| January 31, 2024 | 47.70% |
| December 31, 2023 | 47.70% |
| November 30, 2023 | 47.70% |
| October 31, 2023 | 47.70% |
| September 30, 2023 | 47.60% |
| August 31, 2023 | 41.59% |
| July 31, 2023 | 41.33% |
| June 30, 2023 | 41.33% |
| May 31, 2023 | 36.14% |
| April 30, 2023 | 35.43% |
| March 31, 2023 | 35.43% |
| February 28, 2023 | 32.59% |
| January 31, 2023 | 32.59% |
| December 31, 2022 | 32.59% |
| November 30, 2022 | 32.59% |
| October 31, 2022 | 32.59% |
| September 30, 2022 | 32.59% |
| August 31, 2022 | 32.59% |
| July 31, 2022 | 32.59% |
| June 30, 2022 | 32.59% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AstraZeneca PLC | 27.87% |
| Johnson & Johnson | 18.44% |
| Viatris, Inc. | 81.23% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 3.814 |
| Beta (5Y) | 0.4320 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 21.61% |
| Historical Sharpe Ratio (5Y) | 0.3605 |
| Historical Sortino (5Y) | 0.7498 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 8.11% |